Fortress Biotech Inc (FBIO)
1.70
-0.07
(-3.95%)
USD |
NASDAQ |
Jun 24, 16:00
1.705
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Accounts Payable (Quarterly): 41.80M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 41.80M |
December 31, 2023 | 34.81M |
September 30, 2023 | 44.73M |
June 30, 2023 | 48.59M |
March 31, 2023 | 65.87M |
December 31, 2022 | 57.24M |
September 30, 2022 | 55.76M |
June 30, 2022 | 53.94M |
March 31, 2022 | 44.53M |
December 31, 2021 | 47.43M |
September 30, 2021 | 42.78M |
June 30, 2021 | 14.27M |
March 31, 2021 | 11.37M |
December 31, 2020 | 11.41M |
September 30, 2020 | 32.56M |
June 30, 2020 | 31.84M |
March 31, 2020 | 34.21M |
December 31, 2019 | 35.45M |
September 30, 2019 | 28.51M |
June 30, 2019 | 24.26M |
March 31, 2019 | 37.09M |
December 31, 2018 | 34.22M |
September 30, 2018 | 37.50M |
June 30, 2018 | 38.20M |
March 31, 2018 | 44.85M |
Date | Value |
---|---|
December 31, 2017 | 27.63M |
September 30, 2017 | 31.98M |
June 30, 2017 | 25.00M |
March 31, 2017 | 24.86M |
December 31, 2016 | 24.30M |
September 30, 2016 | 21.83M |
June 30, 2016 | 5.126M |
March 31, 2016 | 2.348M |
December 31, 2015 | 10.44M |
September 30, 2015 | 1.287M |
June 30, 2015 | 0.583M |
March 31, 2015 | 0.664M |
December 31, 2014 | 0.366M |
September 30, 2014 | 0.333M |
June 30, 2014 | 0.331M |
March 31, 2014 | 0.872M |
December 31, 2013 | 0.468M |
September 30, 2013 | 1.114M |
June 30, 2013 | 1.429M |
March 31, 2013 | 0.676M |
December 31, 2012 | 1.029M |
September 30, 2012 | 0.84M |
June 30, 2012 | 0.753M |
March 31, 2012 | 1.001M |
December 31, 2011 | 0.575M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
11.37M
Minimum
Mar 2021
65.87M
Maximum
Mar 2023
38.07M
Average
38.63M
Median
Accounts Payable (Quarterly) Benchmarks
Avenue Therapeutics Inc | 0.31M |
Mustang Bio Inc | 11.28M |
Journey Medical Corp | 15.54M |
Checkpoint Therapeutics Inc | 11.92M |
Viking Therapeutics Inc | 5.225M |